Stanley Druckenmiller Recursion Pharmaceuticals, Inc. Transaction History

Duquesne Family Office LLC

  • $2.95 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$6.59 - $15.86 $3.16 Million - $7.6 Million
-479,183 Reduced 34.57%
906,767 $6.94 Million
Q3 2022

Nov 14, 2022
BUY
$7.83 - $13.6 $8.71 Million - $15.1 Million
1,112,300 Added 406.47%
1,385,950 $14.7 Million
Q1 2022

May 16, 2022
BUY
$6.16 - $18.03 $84,447 - $247,173
13,709 Added 5.27%
273,650 $1.96 Million
Q3 2021

Nov 15, 2021
BUY
$19.03 - $41.33 $4.95 Million - $10.7 Million
259,941 New
259,941 $5.98 Million

Others Institutions Holding RXRX

# of Institutions
286
Shares Held
242M
Call Options Held
1.35M
Put Options Held
2.32M
View Full List

About RECURSION PHARMACEUTICALS, INC.

RXRX Quotes by TradingView
  • Ticker RXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 180,480,000
  • Market Cap $1.12B
  • Description
  • Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...
More about RXRX
Track Stanley Druckenmiller's Portfolio

Track Stanley Druckenmiller Portfolio

Follow Stanley Druckenmiller (Duquesne Family Office LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Duquesne Family Office LLC, based on Form 13F filings with the SEC.

News

Stay updated on Duquesne Family Office LLC and Stanley Druckenmiller with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email